TITLE

Effect of the developmental stage and tissue position on the expression and glycosylation of recombinant glycoprotein GA733-FcK in transgenic plants

AUTHOR(S)
Chae-Yeon Lim; Kyung Jin Lee; Kisung Ko; Doo-Byoung Oh
PUB. DATE
January 2015
SOURCE
Frontiers in Plant Science;Jan2015, Vol. 5, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The influence of developmental stage and position (top, middle, and base) of leaves and stem tissues on the expression and glycosylation pattern of a recombinant therapeutic protein -GA733-FcK- was observed in transgenic seedlings during a 16-week growth period. RNA expression gradually increased with age in the middle and basal leaves and decreased in top leaves after 14 weeks. The protein expression level at all leaf positions increased until 14 weeks and slightly decreased at 16 weeks; it was lower in yellow leaves than in green leaves. In stem, protein expression gradually decreased from the top to the base. The glycosylation patterns of GA733-FcK were analyzed from 10 to 16 weeks. The plant-specific glycans increased in the top leaves at 14 weeks, but only slightly changed in the middle and basal leaves. The structure of glycans varied with tissue position. The glycosylation level in the top and middle leaves increased until 12 and 14 weeks, respectively, and decreased thereafter, whereas it decreased in basal leaves until 14 weeks and increased at 16 weeks. In stem, all three sections showed high-mannose type glycan structures. The area size of the glycans was significantly higher in the top stem than in both the middle and basal stems, and it was smaller in yellow leaves than in green leaves. The glycan profiles were similar between green and yellow leaves until 16 weeks. Thus, biomass-harvesting time should be optimized to obtain recombinant therapeutic proteins with ideal glycan structure profiles.
ACCESSION #
101707811

 

Related Articles

  • N-Glycosylation of Recombinant Therapeutic Glycoproteins in Plant Systems. Balen, Biljana; Krsnik-Rasol, Marijana // Food Technology & Biotechnology;Jan-Mar2007, Vol. 45 Issue 1, p1 

    Transgenic plants have recently emerged as a promising system for low-cost and large-scale production of therapeutic proteins. Despite many advantages plants offer as hosts for expression of recombinant proteins, there are certain limitations caused by major structural differences between plant...

  • Increased yield of heterologous viral glycoprotein in the seeds of homozygous transgenic tobacco plants cultivated underground. Tackaberry, Eilleen S.; Prior, Fiona; Bell, Margaret; Tocchi, Monika; Porter, Suzanne; Mehnic, Jelica; Ganz, Peter R.; Sardana, Ravinder; Altosaar, Illimar; Dudani, Anil // Genome;Jun2003, Vol. 46 Issue 3, p521 

    The use of transgenic plants in the production of recombinant proteins for human therapy, including subunit vaccines, is being investigated to evaluate the efficacy and safety of these emerging biopharmaceutical products. We have previously shown that synthesis of recombinant glycoprotein B (gB)...

  • N-Glycosylation of Recombinant Pharmaceutical Glycoproteins Produced in Transgenic Plants Towards an Humanisation of Plant N-Glycans. Lerouge, P.; bardor, M.; Pagny, S.; Gomord, V.; Faye, L. // Current Pharmaceutical Biotechnology;Dec2000, Vol. 1 Issue 4, p347 

    The number of therapeutic proteins successfully produced in plants is steadily increasing and is expected to grow even more rapidly in the future. Most therapeutic proteins are glycoproteins and N-glycosylation is often essential for their stability, folding and biological activity. Recombinant...

  • Analysis of the N-glycans of recombinant human Factor IX purified from transgenic pig milk. Geun-Cheol Gil; William H Velander; Kevin E Van Cott // Glycobiology;Jul2008, Vol. 18 Issue 7, p526 

    Glycosylation of recombinant proteins is of particular importance because it can play significant roles in the clinical properties of the glycoprotein. In this work, the N-glycan structures of recombinant human Factor IX (tg-FIX) produced in the transgenic pig mammary gland were determined. The...

  • Analysis of the N-glycans of recombinant human Factor IX purified from transgenic pig milk. Geun-Cheol Gil; William H Velander; Kevin E Van Cott // Glycobiology;Jul2008, Vol. 18 Issue 7, p526 

    Glycosylation of recombinant proteins is of particular importance because it can play significant roles in the clinical properties of the glycoprotein. In this work, the N-glycan structures of recombinant human Factor IX (tg-FIX) produced in the transgenic pig mammary gland were determined. The...

  • Malignancy Risk Analysis in Patients with Inadequate Fine Needle Aspiration Cytology (FNAC) of the Thyroid. Al Maqbali, Talib; Tedla, Miroslav; Weickert, Martin O.; Mehanna, Hisham // PLoS ONE;Nov2012, Vol. 7 Issue 11, Special section p1 

    Background: Thyroid fine needle aspiration cytology (FNAC) is the standard diagnostic modality for thyroid nodules. However, it has limitations among which is the incidence of non-diagnostic results (Thy1). Management of cases with repeatedly non-diagnostic FNAC ranges from simple observation to...

  • Glycosides of hydroxyproline: Some recent, unusual discoveries. Taylor, Carol M; Karunaratne, Chamini V; Xie, Ning // Glycobiology;Jun2012, Vol. 22 Issue 6, p757 

    Glycosides of hydroxyproline (Hyp) in the plant cell wall matrix were discovered by Lamport and co-workers in the 1960s. Since then, much has been learned about these Hyp-rich glycoproteins. The intent of this review was to compare and contrast some less common structural motifs, in...

  • Simply better glycoproteins. Lepenies, Bernd; Seeberger, Peter H // Nature Biotechnology;May2014, Vol. 32 Issue 5, p443 

    The authors discuss the paper by L. Meuris and colleagues regarding the use of an elegant method called GlycoDelete to reduce N-glycan heterogeneity of recombinant glycoproteins in mammalian cells. They mention that the authors performed manipulation to the glycosylation machinery in the Golgi...

  • Plants as factories for production of biopharmaceutical and bioindustrial proteins: lessons from cell biology. Kermode, Allison R. // Canadian Journal of Botany;Apr2006, Vol. 84 Issue 4, p679 

    Transgenic plants, seeds, and cultured plant cells are potentially one of the most economical systems for large-scale production of recombinant proteins for industrial and pharmaceutical uses. Biochemical, technical, and economic concerns with current production systems have generated enormous...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics